{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:49:31Z","timestamp":1781304571809,"version":"3.54.1"},"reference-count":42,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2024,4,4]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the impact of the different types of neoplasms and lineages on mortality of patients with SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Retrospective and observational comparison of the neoplasm-related deaths in patients with SLE and the general Spanish population reported in the Spanish Hospital Discharge Database. To determine the impact of SLE on the risk of dying from each neoplasm lineage, a binary logistic regression considering age, female sex, tobacco and alcohol consumption, was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During 2016\u20132019, 139 531 in-hospital deaths from neoplasms were certified in Spain (91 in patients with SLE). Patients with SLE presented a lower mortality rate from solid organ neoplasms, (80.2% vs 91.1%, OR 0.393), linked to their lower risk of colorectal carcinoma (1.1% vs 10.8%, OR 0.110). By contrast, gynaecological neoplasms presented a higher risk (8.8% vs 3%, OR 3.039) in the deceased patients with SLE, associated with the higher frequency of vulvar neoplasms (2% vs 0.2%, OR 14.767) and cervical carcinomas (3.3% vs 0.5%, OR 3.809). Haematological neoplasm-related deaths were also more prevalent in patients with SLE (19.8% vs 8.9%, OR 2.546), mostly attributable to the higher proportion of deaths due to non-Hodgkin\u2019s lymphoma (11% vs 2.9%, OR 4.060) of B cell lineage (9.9% vs 2.5%, OR 4.133).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with SLE present a higher risk of death from vulvar neoplasms, cervical carcinomas and B-cell non-Hodgkin\u2019s lymphoma in comparison with the general Spanish population. In addition to developing strategies that might help to attenuate their occurrence and impact, such as decreasing the immunosuppressive burden, specific early detection programmes for these conditions should be investigated and considered carefully.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2024-001153","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T12:40:55Z","timestamp":1713357655000},"page":"e001153","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Higher mortality risk from gynaecological neoplasms and non-Hodgkin\u2019s lymphoma in patients with systemic lupus erythematosus: an observational study from the Spanish National Registry"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-4514","authenticated-orcid":false,"given":"V\u00edctor","family":"Moreno-Torres","sequence":"first","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"},{"name":"Health Sciences School and Medical Center, UNIR, Logrono, La Rioja, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Mart\u00ednez-Urbistondo","sequence":"additional","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"V\u00e1zquez-Comendador","sequence":"additional","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Mateos Seirul-lo","sequence":"additional","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Castej\u00f3n","sequence":"additional","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Huerta","sequence":"additional","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Dur\u00e1n-del Campo","sequence":"additional","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Tutor","sequence":"additional","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Mellor-Pita","sequence":"additional","affiliation":[{"name":"Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"2025091514311103000_11.1.e001153.1","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025091514311103000_11.1.e001153.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60128-8"},{"key":"2025091514311103000_11.1.e001153.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.21955"},{"key":"2025091514311103000_11.1.e001153.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000091181.93122.55"},{"key":"2025091514311103000_11.1.e001153.5","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0102"},{"key":"2025091514311103000_11.1.e001153.6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1177\/0961203319877947","article-title":"Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population","volume":"28","author":"Ingvarsson","year":"2019","journal-title":"Lupus"},{"key":"2025091514311103000_11.1.e001153.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089"},{"key":"2025091514311103000_11.1.e001153.8","doi-asserted-by":"crossref","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","article-title":"Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors","volume":"59","author":"Arnaud","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025091514311103000_11.1.e001153.9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245749","article-title":"Trends in hospital admissions and death causes in patients with systemic lupus erythematosus: Spanish National Registry","volume":"10","author":"Moreno-Torres","year":"2021","journal-title":"J Clin Med"},{"key":"2025091514311103000_11.1.e001153.10","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000711","article-title":"Impact of severe infections in SLE: an observational study from the Spanish National Registry","volume":"9","author":"Moreno-Torres","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2025091514311103000_11.1.e001153.11","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1519394"},{"key":"2025091514311103000_11.1.e001153.12","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000648"},{"key":"2025091514311103000_11.1.e001153.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.09.013"},{"key":"2025091514311103000_11.1.e001153.14","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315627202"},{"key":"2025091514311103000_11.1.e001153.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214802"},{"key":"2025091514311103000_11.1.e001153.16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091514311103000_11.1.e001153.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100236","article-title":"Sarcoidosis and lymphoma mortality risk: an observational study from the Spanish National Registry","volume":"8","author":"Moreno-Torres","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"2025091514311103000_11.1.e001153.18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/qjmed\/hcac215","article-title":"Predictors of in-hospital mortality in HIV-infected patients with COVID-19","volume":"116","author":"Moreno-Torres","year":"2023","journal-title":"QJM"},{"key":"2025091514311103000_11.1.e001153.19","doi-asserted-by":"crossref","first-page":"103341","DOI":"10.1016\/j.autrev.2023.103341","article-title":"Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: a nation-wide population study","volume":"22","author":"Moreno-Torres","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025091514311103000_11.1.e001153.20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12283","article-title":"The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large\u2010scale cohort study in China","volume":"42","author":"Zhou","year":"2022","journal-title":"Cancer Communications"},{"key":"2025091514311103000_11.1.e001153.21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/acr.24425","article-title":"Cancer risk in a large inception systemic lupus erythematosus cohort: effects of demographic characteristics, smoking, and medications","volume":"73","author":"Bernatsky","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091514311103000_11.1.e001153.22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/rheumatology\/keac258","article-title":"Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study","volume":"62","author":"Mart\u00edn-L\u00f3pez","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025091514311103000_11.1.e001153.23","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.38731","article-title":"Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis","volume":"66","author":"Thomas","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025091514311103000_11.1.e001153.24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s12026-016-8885-8","article-title":"Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study","volume":"65","author":"Azrielant","year":"2017","journal-title":"Immunol Res"},{"key":"2025091514311103000_11.1.e001153.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.21029"},{"key":"2025091514311103000_11.1.e001153.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.12.009"},{"key":"2025091514311103000_11.1.e001153.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025091514311103000_11.1.e001153.28","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001122"},{"key":"2025091514311103000_11.1.e001153.29","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/rheumatology\/keaa537","article-title":"Systemic autoimmune disease as a cause of death: mortality burden and comorbidities","volume":"60","author":"Mitratza","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025091514311103000_11.1.e001153.30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1177\/09612033221122163","article-title":"Factors mediating cancer risk in systemic lupus erythematosus","volume":"31","author":"Hardenbergh","year":"2022","journal-title":"Lupus"},{"key":"2025091514311103000_11.1.e001153.31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: incidence, pathogenesis and biology","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"key":"2025091514311103000_11.1.e001153.32","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02692-8","article-title":"Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis\u2014a case-control study","volume":"24","author":"Zhang","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025091514311103000_11.1.e001153.33","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.067777"},{"key":"2025091514311103000_11.1.e001153.34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"2025091514311103000_11.1.e001153.35","doi-asserted-by":"crossref","unstructured":"Goulenok T , Mendes C , Dayan L , et al . Improving human papillomavirus-related cervical cancer screening in patients with systemic lupus erythematosus. J Rheumatol 2023;2022\u20131335. doi:10.3899\/jrheum.2022-1335","DOI":"10.3899\/jrheum.2022-1335"},{"key":"2025091514311103000_11.1.e001153.36","article-title":"EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis","volume":"10","author":"Parodis","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025091514311103000_11.1.e001153.37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10897"},{"key":"2025091514311103000_11.1.e001153.38","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP)","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"2025091514311103000_11.1.e001153.39","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21616"},{"key":"2025091514311103000_11.1.e001153.40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.230082"},{"key":"2025091514311103000_11.1.e001153.41","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-022-02878-8","article-title":"Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a lupus Midwest network (LUMEN) study","volume":"24","author":"Chevet","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025091514311103000_11.1.e001153.42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220105"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2024-001153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:31:20Z","timestamp":1757971880000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2024-001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4,17]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/lupus-2024-001153"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2024-001153","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}